Elevation Oncology supports the utilization of genomic testing for all individuals, as every patient deserves insight into the unique factors propelling the growth of their tumor. We design tailored precision medications to align with these distinct genomic catalysts, recognizing that comprehending the cause of tumor growth is insufficient without access to effective treatments. Our advocacy extends to fostering collaboration within research and industry networks, recognizing the intricate nature of cancer treatment. Only through collective effort can our community develop a sufficient array of precise therapeutic options to ensure actionable results from every genomic test, thus improving outcomes for our patients.